Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-28T06:39:49.828Z Has data issue: false hasContentIssue false
  • English
  • Français

Rauwolfia Alkaloids and Reserpine in the Treatment of the Chronic Psychotic Patient

Published online by Cambridge University Press:  08 February 2018

Charmian Elkes
Charmian Elkes*
Affiliation:
All Saints Hospital, Birmingham
Get access Rights & Permissions [Opens in a new window]

Extract

Reports on the use of Rauwolfia alkaloids in the treatment of the mentally disturbed and on the remarkable central properties of this group of agents have encouraged a trial of the effect of both mixed Rauwolfia alkaloids, and of reserpine in the management and treatment of the chronic psychotic patient.

Type
Original Articles
Information
Journal of Mental Science , Volume 103 , Issue 432 , July 1957 , pp. 464 - 474
Copyright
Copyright © Royal College of Psychiatrists, 1957 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Achor, R. W. P., Hanson, N. O., and Gifford, R. W., “Hypertension treated with Rauwolfia Serpentina (whole root) and with Reserpine”, J. Amer. Med. Ass., 1955, 159, 841.Google Scholar
Barsa, J. A., and Kline, N. S., “Combined Reserpine-Chlorpromazine in Treatment of Disturbed Psychotics”, Arch. Neurol. Psych., 1955, 74, 280.CrossRefGoogle ScholarPubMed
Bein, H. J., “Significance of selected central mechanisms for analysis of the action of reserpine”, Ann. N.Y. Acad. Science, 1955, 61, 4.CrossRefGoogle ScholarPubMed
Campden-Main, B. C., and Wegeelski, Z., “Control of deviant behaviour in chronically disturbed psychotic patients by the oral administration of Reserpine”, Ann. N. Y. Acad. Science, 1955, 61, 117.Google Scholar
Dasgupta, IS. R., Ray, G. K., and Werner, G., “Central Actions of Rauwolfia Serpentina”, Ind. J. Med., Sci., 1953, 11, 597.Google Scholar
Davies, D. L., and Shepherd, M., “Reserpine in the Treatment of Anxious and Depressed Patients”, Lancet, 1955, ii, 117.Google Scholar
Elkes, J., and Elkes, C., “Effect of chlorpromazine on the behaviour of chronically overactive psychotic patients”, Britt Med. J., 1954, ii, 560.CrossRefGoogle Scholar
Foote, E. S., “Reserpine in the treatment of Chronic Psychotics”, Brit. Med. J., 1955, i, 1192.Google Scholar
Gupta, J. C., Deb, A. K., and Kahali, B. S., “Preliminary observations on the use of Rauwolfia Serpentina in the treatment of mental disorders”, Indian Med. Gaz., 1943, 78, 547.Google ScholarPubMed
Hollister, L. E., Krieger, G. E., Kringel, A., and Roberts, R. H., “Treatment of Chronic Schizophrenia reactions with Reserpine”, Ann. N.Y. Acad. Sci., 1955, 61, 92.CrossRefGoogle ScholarPubMed
Hoffman, J. L., and Konchegul, L., “Clinical and Psychological observations on Psychiatric Patients treated with Reserpine: A preliminary report”, Ann. N.Y. Acad. Sci., 1955, 61, 144.Google Scholar
Kline, N. S., and Stanley, A. M., “Use of Reserpine in a Neuropsychiatric Hospital”, Ann. N. Y. Acad. Sci., 1955, 61, 85.Google Scholar
Moore, J. N. P., “Tranquillizers in Psychiatry”, Meeting of R.M.P.A., London, 9 February, Brit. Med. J., 1956, i, 512.Google Scholar
Morgan, D. R., “Combined use of Chlorpromazine and Reserpine in the treatment of Chronic Mental illness”, Med. J. Australia, 1955, 3, 77.Google Scholar
Muller, J. C., Pryor, W. W., Gibbons, J. E., and Orgain, E. E., “Depression and Anxiety occurring during Rauwolfia therapy”, J. Amer. Med. Ass., 1955, 159, 836.CrossRefGoogle ScholarPubMed
Noce, R. H., Williams, D. B., and Rapaport, W., “Reserpine in the management of the mentally ill”, J. Amer. Med. Ass., 1955, 158, 11.Google Scholar
Schneider, J. A., Plummer, A. J., Earl, A. E., and Gaunt, R., “Neuropharmacological aspects of reserpine”, Ann. N.Y. Acad. Sci., 1955, 61, 17.Google Scholar
Smirk, F. H., and McQueen, E. G., “Comparison of Rescinnamine and Reserpine as Hypotensive agents”, Lancet, 1955, ii, 115.CrossRefGoogle Scholar
Pletcher, A., Shore, P. A., and Brodie, B. B., “Serotonin Release as a Possible Mechanism of Reserpine Action”, Science, 1955, 122, 374.Google Scholar
Zeller, W. W., Graffagnino, P. N., Cullen, C. F., and Rietman, H. J., “Use of Chlorpromazine and Reserpine in the treatment of emotional disorders”, J. Amer. Med. Ass., 1956, 160, 179.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.